Is There a Role of Coronary CTA in Primary Prevention? Current State and Future Directions.
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11883-021-00943-2
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2021 AND VI 23 AND IP 8
Results: 8
1
2
Special Considerations for Lipid-Lowering Therapy in Women Reflecting Recent Randomized Trials.
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11883-021-00942-3
- By:
- Publication type:
- Article
3
Hypertension in Women Across the Lifespan.
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11883-021-00941-4
- By:
- Publication type:
- Article
4
Lipoprotein (a): Recent Updates on a Unique Lipoprotein.
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11883-021-00940-5
- By:
- Publication type:
- Article
5
The Genetic Basis of Hypertriglyceridemia.
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11883-021-00939-y
- By:
- Publication type:
- Article
6
Novel RNAi-Based Therapies for Atherosclerosis.
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11883-021-00938-z
- By:
- Publication type:
- Article
7
Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy.
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11883-021-00937-0
- By:
- Publication type:
- Article
8
The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently?
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11883-021-00936-1
- By:
- Publication type:
- Article